Introduction {#Sec1}
============

Diabetic retinopathy (DR), which results from chronic high blood glucose levels, is one of the most common and serious complications of diabetes mellitus, which is the main cause of adult-acquired blindness \[[@CR1]\]. A recent meta-analysis of 243 population-based studies shows that globally, in 2010, out of 32.4 million blind and 191 million visually impaired people, 0.8 million were blind and 3.7 million were visually impaired because of DR \[[@CR2]\]. Another meta-analysis, based on 288 studies, concluded that 2.6 million people were visually impaired (blindness and moderate to severe vision impairment) from DR in 2015 and this is estimated to rise to 3.2 million in 2020 \[[@CR3]\]. Furthermore, DR leads to a poor quality of life and an increased risk of other diabetes complications and mortality, which brings severe social burden \[[@CR4], [@CR5]\]. Currently, DR is mainly treated by laser photocoagulation of the retina, anti-vascular endothelial growth factor (VEGF) drug therapy, hormone therapy, and surgical treatment. However, these treatments might contribute to certain adverse reactions, such as the increase of angiogenesis, rise intraocular pressure, and retinal hemorrhage \[[@CR6], [@CR7]\] and the effect of single or combined treatment is limited. Therefore, it is urgent to discover potential therapeutic targets and develop new therapeutic strategies for the treatment of DR.

Traditional Chinese Medicine (TCM) is a comprehensive medicinal system that is characterized by its satisfying therapeutic effects and minor side effects. TCM is widely used in Asian countries, especially China \[[@CR8]\]. TCM is characterized by multiple ingredients that have a variety of advantages, such as synergy, reduction of side effects, and improvement of adaptive resistance \[[@CR9]\]. TCM network pharmacology not only identifies and optimizes multiple target interventions by modeling signaling pathways and specific processes \[[@CR10]\], but also measures the efficacy of drugs, especially multi-target drugs \[[@CR11]\]. Recently, TCM network pharmacology has been widely applied to the exploration of complex diseases, such as cancer, renal injury, and heart failure \[[@CR12]--[@CR14]\]. Based on the theory of traditional Chinese herbal medical science, TCM can offer a treatment for the prevention and treatment of DR in a systematic way. *Radix Salviae* is a species of Labiatae that is distributed throughout the country. As a traditional medicinal plant, it has satisfactory drug efficacy for the alleviation of DR, which indicates the existence of certain pharmacological components in *Radix Salviae* \[[@CR15]\]. We discovered, in clinical practice, that *Radix Salviae* can effectively relieve the clinical symptoms of DR, such as local visual field defects, vision loss, and visual impairment \[[@CR16]\]. However, the pharmacological mechanisms of *Radix Salviae* are still unknown.

With the rapid development of bioinformatics, systems biology, and poly-pharmacology, network pharmacology, based on the concept of "Disease-Gene-Target-Medicine", can explore the complex mechanisms of medicine on the human body \[[@CR17]\]. This is in keeping with the holistic view of TCM and the mechanisms of TCM formulas are multi-ingredient, multi-pathway, and multi-target \[[@CR18]\].

The aim of our study was to screen the related ingredients of *Radix Salviae* using multiple databases and acquire the potential targets by target fishing. Then, we aimed to screen the related targets of DR by consolidation of a multi-source database. Based on the matching results between *Radix Salviae* potential targets and DR targets, we aimed to build a protein--protein interaction (PPI) network to analyze the interactions among these targets and screen the hub targets based on topology. Moreover, using The Database for Annotation, Visualization and Integrated Discovery (DAVID) bioinformatics resources, we aimed to obtain the enrichment analysis of the Gene Ontology Biological Process (GO-BP) and Kyoto Encyclopedia of Genes and Genomes (KEGG). This study is necessary to investigate how *Radix Salviae* alleviates DR via the molecular mechanisms predicted by network pharmacology and how the network pharmacology approach can be an effective tool to reveal the mechanisms of TCM. The flowchart of the experimental procedures of our study is shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1The flowchart of the network pharmacology-based strategy for deciphering the mechanisms of *Radix Salviae* on DR

Methods {#Sec2}
=======

Data preparation {#Sec3}
----------------

### Chemical ingredients database building {#Sec4}

To collect the ingredients in *Radix Salviae*, we used the Traditional Chinese Medicine System Pharmacology Database \[[@CR19]\] (TCMSP, <http://lsp.nwu.edu.cn/tcmsp.php>, 2019.8.11), a specialized pharmacological platform for TCM. Two hundred and two herbal ingredients were recorded in this process.

Active ingredients screening {#Sec5}
----------------------------

### Oral bioavailability (OB) prediction {#Sec6}

OB is the percentage of an orally administered drug that reaches the systemic circulation. It is one of the most used pharmacokinetic properties in drug screening. In this process, the OB threshold was set as 30% and those ingredients with OB ≥ 30% were selected as the active ingredients for the next step \[[@CR20]\].

### Drug-likeness (DL) evaluation {#Sec7}

DL is a molecular parameter that measures the absorption, distribution, metabolism, and excretion of drug molecules affected by their pharmacokinetics. By evaluating prospective "drug-like" compounds, DL optimizes the pharmacokinetic and pharmaceutical properties, such as chemical stability and solubility. The DL level of the compounds was set as 0.18, as this is the selection criterion for "drug-like" compounds in traditional Chinese herbs \[[@CR21]\]. In this study, those ingredients with DL ≥ 0.18 were selected.

Target fishing {#Sec8}
--------------

The active ingredients of drugs play a role in related biological functions via targets. Our study located targets by target fishing based on the candidate ingredients. Retrieving the small molecular structure information of the active ingredients in *Radix Salviae* on the PubChem database (<https://pubchem.ncbi.nlm.nih.gov/>), we fished targets with a screening online tool called the Swiss Target Prediction webserver \[[@CR22]\] (<http://www.swisstargetprediction.ch/index.php>).

Disease targets database building {#Sec9}
---------------------------------

We collected DR targets from four source databases. The databases used in our study were: the DrugBank database (<http://www.drugbank.ca/>, version 4.3, 2019.8.11), Online Mendelian Inheritance in Man (OMIM) database \[[@CR23]\] (<http://www.omim.org/>, 2019.8.11), DisGeNET v6 database \[[@CR24]\] (<http://www.disgenet.org/>, version 6.0, 2019.8.11), and Genetic Association Database \[[@CR25]\] (<https://www.geneticassociationdb.nih.gov/>, 2019.8.11).

Finally, we matched the prediction of the targets of *Radix Salviae* active ingredients and the retrieval of the related targets of DR and chose the overlapping targets as the related targets of *Radix Salviae* for the treatment of DR. The targets were then processed by String \[[@CR26]\] (<https://string-db.org/>, 2019.8.13) to draw the data of PPI.

Network construction {#Sec10}
--------------------

### Network construction method {#Sec11}

\(1\) Compound-target network (C-T network); (2) *Radix Salviae* target-DR target interactional network (T-T network); (3) Target-pathway network (T-P network). The pathway information of targets was screened from the result of KEGG pathway enrichment. Cytoscape3.6.0 (<http://www.cytoscape.org/>, 2019.8.14), an open-source software platform for visualizing complex networks and integrating these with any type of attribute data, helped build visualized network graphs \[[@CR27]\].

### Network topological feature set definition {#Sec12}

We selected two parameters to evaluate the topological features of every node in the interaction network. "Degree" is defined as the number of links to a node, which reflects the frequency of interaction between a node and other nodes \[[@CR28]\]. "Closeness Centrality" measures the mean distance from one node to another. A geodesic path is the shortest path through a network between nodes \[[@CR29]\]. The more important the output of a node, the higher the value of this node in the network. Therefore, the levels of the two parameters represent the topological importance of the nodes in the network.

Enrichment analysis {#Sec13}
-------------------

We used DAVID (<https://david.ncifcrf.gov/>, v6.8,2019.8.14) \[[@CR30]\] for GO enrichment analysis and KEGG (<http://www.kegg.jp/>, 2019.8.14) \[[@CR31]\] for pathway enrichment analysis.

Results {#Sec14}
=======

Active compounds in *Radix Salviae* {#Sec15}
-----------------------------------

Retrieved from TCMSP, there were 202 related components in the whole formula in total. According to the active ingredient screening thresholds of OB ≥ 30% and DL ≥ 0.18, 65 active ingredients were selected.

Target prediction and analysis {#Sec16}
------------------------------

We conducted target fishing on the 65 active ingredients based on chemical similarity, obtaining 287 related targets. The 65 active compounds that were obtained are listed in Table [1](#Tab1){ref-type="table"}.Table 1The list of 65 compounds of *Radix Salviae* and their OB and DLIDCompoundOBDLMOL0016011,2,5,6-Tetrahydrotanshinone38.750.36MOL001659Poriferasterol43.830.76MOL001771Poriferast-5-en-3beta-ol36.910.75MOL001942Isoimperatorin45.460.23MOL002222Sugiol36.110.28MOL002651Dehydrotanshinone II A43.760.4MOL002776Baicalin40.120.75MOL000569Digallate61.850.26MOL000006Luteolin36.160.25MOL006824α-Amyrin39.510.76MOL0070365,6-Dihydroxy-7-isopropyl-1,1-dimethyl-2,3-dihydrophenanthren-4-one33.770.29MOL0070412-Isopropyl-8-methylphenanthrene-3,4-dione40.860.23MOL0070453α-HydroxytanshinoIIa44.930.44MOL007048(E)-3-\[2-(3,4-dihydroxyphenyl)-7-hydroxy-benzofuran-4-yl\]acrylic acid48.240.31MOL0070494-Methylenemiltirone34.350.23MOL0070502-(4-Hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-benzofurancarboxaldehyde62.780.4MOL0070516-*o*-Syringyl-8-o-acetyl shanzhiside methyl ester46.690.71MOL007058Formyltanshinone73.440.42MOL0070593-Beta-hydroxymethyllenetanshiquinone32.160.41MOL007061Methylenetanshinquinone37.070.36MOL007063Przewalskin a37.110.65MOL007064Przewalskin b110.320.44MOL007068Przewaquinone B62.240.41MOL007069Przewaquinone c55.740.4MOL007070(6S,7R)-6,7-dihydroxy-1,6-dimethyl-8,9-dihydro-7H-naphtho\[8,7-g\]benzofuran-10,11-dione41.310.45MOL007071Przewaquinone f40.310.46MOL007077Sclareol43.670.21MOL007079Tanshinaldehyde52.470.45MOL007081Danshenol B57.950.56MOL007082Danshenol A56.970.52MOL007085Salvilenone30.380.38MOL007088Cryptotanshinone52.340.4MOL007093Dan-shexinkum d38.880.55MOL007094Danshenspiroketallactone50.430.31MOL007098Deoxyneocryptotanshinone49.40.29MOL007100Dihydrotanshinlactone38.680.32MOL007101Dihydrotanshinone I45.040.36MOL007105Epidanshenspiroketallactone68.270.31MOL007107C0909236.070.25MOL007108Isocryptotanshi-none54.980.39MOL007111Isotanshinone II49.920.4MOL007115Manool45.040.2MOL007118Microstegiol39.610.28MOL007119Miltionone I49.680.32MOL007120Miltionone II71.030.44MOL007121Miltipolone36.560.37MOL007122Miltirone38.760.25MOL007123Miltirone II44.950.24MOL007124Neocryptotanshinone ii39.460.23MOL007125Neocryptotanshinone52.490.32MOL0071271-Methyl-8,9-dihydro-7H-naphtho\[5,6-g\]benzofuran-6,10,11-trione34.720.37MOL007130Prolithospermic acid64.370.31MOL007132(2R)-3-(3,4-dihydroxyphenyl)-2-\[(Z)-3-(3,4-dihydroxyphenyl)acryloyl\]oxy-propionic acid109.380.35MOL007140(Z)-3-\[2-\[(E)-2-(3,4-dihydroxyphenyl)vinyl\]-3,4-dihydroxy-phenyl\]acrylic acid88.540.26MOL007141Salvianolic acid g45.560.61MOL007142Salvianolic acid j43.380.72MOL007143Salvilenone I32.430.23MOL007145Salviolone31.720.24MOL007149NSC 12242134.490.28MOL007150(6S)-6-Hydroxy-1-methyl-6-methylol-8,9-dihydro-7H-naphtho\[8,7-g\]benzofuran-10,11-quinone75.390.46MOL007151Tanshindiol B42.670.45MOL007152Przewaquinone E42.850.45MOL007154Tanshinone iia49.890.4MOL007155(6S)-6-(hydroxymethyl)-1,6-dimethyl-8,9-dihydro-7H-naphtho\[8,7-g\]benzofuran-10,11-dione65.260.45MOL007156Tanshinone VI45.640.3

The target data on DR from OMIM, Drugbank, GAD, and DisGeNet was integrated. Eighteen targets that matched the related targets of *Radix Salviae* on DR were collected as related targets for the effect of *Radix Salviae* on DR (Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}).Fig. 2The C-T network that consists of 24 nodes and 247 targets. Yellow and blue nodes denote the compounds and targets, respectively Fig. 3The T-D network that consists of 287 nodes and 247 targets. Pink and yellow nodes denote the diseases and targets, respectively

In the String database, the PPI network of the 18 targets was established. The details are shown in Fig. [4](#Fig4){ref-type="fig"}. There were 18 nodes and 40 edges in total. The topological feature analysis of the PPI selected targets used median values to determine key targets and constructed the big hub nodes as the main targets that may cause the effect of *Radix Salviae* on DR, based on "degree" and "closeness certainty". The threshold values were degree ≥ 4.8 and closeness ≥ 0.51 and the results settled at 18 hub nodes and 40 edges. The details are shown in Fig. [5](#Fig5){ref-type="fig"}, which includes prostaglandin-endoperoxide synthase 2 (PTGS2) (degree = 12), matrix metallopeptidase 9 (MMP9) (degree = 10), vascular endothelial growth factor receptor 2 (KDR) (degree = 8), matrix metallopeptidase 2 (MMP2) (degree = 7), plasminogen (PLG) (degree = 6), androgen receptor (degree = 5), matrix metallopeptidase 3 (MMP3) (degree = 5), and insulin-like growth factor 1 (IGF-1) receptor (degree = 5).Fig. 4The 18 matching targets of the related targets in *Radix Salviae* on DR. *DR* diabetic retinopathy Fig. 5PPI network of 18 nodes and 40 edges established in the String database

GO biological process and KEGG pathway enrichment analysis {#Sec17}
----------------------------------------------------------

DAVID v6.8 was used for enrichment analysis of the 18 targets. The screening threshold was P \< 0.01 and 30 GO items were retrieved. We selected 10 KEGG pathways for analysis.

GO biological process enrichment analysis {#Sec18}
-----------------------------------------

The 30 biological processes were mainly involved in angiogenesis, protein metabolism, inflammatory response, apoptosis, and cell proliferation. The details are shown in Fig. [6](#Fig6){ref-type="fig"}. The processes were, in the aspect of angiogenesis: angiogenesis (GO:0001525) and positive regulation of vascular smooth muscle cell proliferation (GO:1904707); in the aspect of protein metabolism: proteolysis (GO:0006508), collagen catabolic process (GO:0030574), cellular protein metabolic process (GO:0044267), negative regulation of fibrinolysis (GO:0051918), and fibrinolysis (GO:0042730); in the aspect of inflammatory response: regulation of type I interferon-mediated signaling pathway (GO:0060338), doxorubicin metabolic process (GO:0044598), and oxidation--reduction process (GO:0055114); in the aspect of apoptosis: negative regulation of apoptotic process (GO:0043066); and, in the aspect of cell proliferation: positive regulation of cell proliferation (GO:0008284), negative regulation of cell proliferation (GO:0008285), positive regulation of vascular smooth muscle cell proliferation (GO:1904707), and positive regulation of smooth muscle cell proliferation (GO:0048661). Based on these five main aspects, a complex multi-path synergetic effect may be the cause of the effect of *Radix Salviae* on DR.Fig. 6Main 30 GO biological process by major hubs from the DAVID database

### KEGG pathway enrichment analysis {#Sec19}

We conducted KEGG pathway enrichment analysis on 18 targets and screened 10 signaling pathways: pentose and glucuronate interconversions (hsa00040), glycerol-lipid metabolism (hsa00561), arachidonic acid metabolism (hsa00590), adherens junction (hsa04520), tumor necrosis factor signaling pathway (hsa04668), serotonergic synapse (hsa04726), linoleic acid metabolism (hsa00591), galactose metabolism (hsa00052), and fructose and mannose metabolism (hsa00051),and bladder cancer (hsa05219). The details are shown in Fig. [7](#Fig7){ref-type="fig"}.Fig. 7The main 10 pathways enriched by major hubs from the DAVID database

Discussion {#Sec20}
==========

We discovered that *Radix Salviae* significantly alleviated the symptoms of DR and believe that its impact may be related to its potential function. Hence, we explored the potential mechanism by the network pharmacology approach. DR is one of the most common and serious microvascular complications in type 2 diabetes patients. The basic pathological changes of DR include the loss of perithelial cell selectivity, thickening of the basement membrane, formation of microangioma, proliferation of endothelial cells, and neovascularization \[[@CR32]\].

Angiogenesis {#Sec21}
------------

### We discovered that the anti-angiogenesis effect of *Radix Salviae* may be a factor in its treatment of DR {#Sec22}

During hyperglycemia, the activity of MMP9 is increased and the degradation of the basement membrane is accelerated, which degrades the cell matrix in the basement membrane, loosens the cell structure, and provides nutrients and growth space for the formation of new blood vessels \[[@CR33]\]. KDR modulates angiogenic responses such as endothelial cell migration and proliferation. VEGF acts through high-affinity receptors and some consist of KDR \[[@CR34]\].

VEGF is of major importance in proliferative DR \[[@CR35]\] and can induce vascular abnormalities including vascular leakage and neovascularisation \[[@CR36]\]. The VEGF and VEGFR system plays a major role in retinal neovacularization \[[@CR37]\]. The inhibition of the binding of VEGF to its receptor can reduce neovacularization \[[@CR38]\]. The role of VEGF in the pathogenesis of diabetic macular edema (DME) has been widely recognized. The intravitreal injection of anti-VEGF drugs has achieved good effects in the improvement of vision and reduction of macular edema and has become the initial therapy for DME \[[@CR39]\]. Anti-VEGF treatment of proliferative DR may be superior to pan-retinal photocoagulation (PRP) and may delay or reduce the need for vitrectomy in vitreous hemorrhage cases when PRP is not possible \[[@CR6]\]. Anti-VEGF therapeutics, including bevacizumab, ranibizumab, and aboxicept, are effective treatments for central macular edema \[[@CR40]\].

PLG is a blood zymogen that is activated by proteolysis and converted to plasmin and angiostatin. Plasmin dissolves fibrin in blood clots and is an important protease in many other cellular processes, whereas angiostatin inhibits angiogenesis. Defects in *PLG* are likely a cause of thrombophilia. Tissue plasminogen activator (t-PA) and its inhibitor (PAI), participate in neovascularization, particularly in VEGF expression. Vascular tissue formation and new matrix component production is the basis of vascular proliferation. t-PA plays a major role in endothelial cell matrix degradation, which is an important precondition for endothelial cell proliferation and migration \[[@CR41]\]. In addition, the expression of both t-PA and PAI is significantly correlated with VEGF expression \[[@CR42]\].

IGF-1 stimulates growth, differentiation, and metabolism in a variety of cell types and plays a crucial role in both embryonic and postnatal growth. IGF-I is synthesized by the liver and acts on the tyrosine-kinase receptor (IGF-1R). IGF-1 expression is preserved in many tissues, including the retina \[[@CR43]\]. Several retinal cell types, such as endothelial and retinal pigment epithelium cells, express both IGF-1 and its receptor. Injected IGF-1 induces retinal neovascularization and blood-retinal barrier breakdown in several in vitro studies \[[@CR44]\].

Apoptosis {#Sec23}
---------

### We discovered that the inhibition of apoptosis induced by *Radix Salviae* may be a factor in its treatment of DR {#Sec24}

In the pathogenesis of DR, retinal microvascular cells (pericytes and endothelial cells) and other cells, including glial cells and neuronal cells, are lost selectively via apoptosis \[[@CR45]\]. Apart from this, the accelerated loss of capillary cells may increase oxidative stress and inflammatory mediators \[[@CR46]\]. In addition, the high level of manganese superoxide in the mitochondria has an important role in DR \[[@CR47]\].

MMP, a member of the proteinase family, regulates major biological functions, including tissue repair and cell signaling. Among the MMPs, MMP2 is the most ubiquitous \[[@CR48]\]. Activated MMP2 in the mitochondria results in the accelerated apoptosis of retinal capillary cells in diabetes, which damages the retinal mitochondria by modulating Hsp60 and connexin 43 and allows cytochrome c to leak out and activate apoptotic machinery \[[@CR49]\].

Inflammatory response {#Sec25}
---------------------

### We discovered that the induction of the inflammatory response by *Radix Salviae* may be a factor in its treatment of DR {#Sec26}

Prostaglandin-endoperoxide synthase, also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis and acts as both a dioxygenase and peroxidase. PTGS2, which is often called cyclooxygenase 2 (COX-2), is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. In the plasma membrane, hyperglycemia activates aquaporin-1, which can sense osmolarity changes, and an "osmosignaling" pathway, which involves the transcription factor tonicity enhancer binding protein, which transmits the signal towards effector regulatory sites in the nuclei. This further promotes the expression of pro-inflammatory genes such as adhesion molecules and COX-2 \[[@CR50]\].

Radix Salviae {#Sec27}
-------------

*Radix Salviae* is one of the most popular Chinese herbs and has been used for centuries for the management of cardiovascular and cerebrovascular diseases \[[@CR51]\]. There are several studies that demonstrate that *Radix Salviae* can effectively reduce apoptosis, cell proliferation, and neovascularization. Liu et al. \[[@CR52]\] believed that Danhong injection (DHI) could induce the expression of insulin receptor substrate 1, fibroblast growth factor 21, and peroxisome proliferator-activated receptor gamma in the liver and peripheral tissues, which can increase insulin sensitivity. Furthermore, the induction of genes involved in lipolysis, fatty acid oxidation, and mitochondrial biogenesis suggests that DHI may enhance energy metabolism. Moreover, DHI inhibits CRISPR-associated gene 3, MMP2, and MMP9 expression and the formation of acellular capillaries in retinas; thus, DHI can prevent diabetes-induced apoptosis and protect retinas against diabetes-induced damage. Salvianolic acid B (Sal B), one of the major water-soluble compounds isolated from *Radix Salviae*, can inhibit high glucose-induced cell proliferation by releasing the cell from G1 phase arrest and delaying S phase progression in human mesangial cells. Sal B can decrease the secretion of high glucose-induced MMP2 and MMP9, which is partly mediated by blocking NF-κB activation \[[@CR53]\]. Sal A has a wide range of pharmacological effects, such as anti-inflammatory, antioxidant, and anti-fibrotic properties \[[@CR51], [@CR54], [@CR55]\]. In addition, the Chinese herbal compound *Radix Salviae* is widely used in clinical practice. A recent meta-analysis shows that the herb *Salvia miltiorrhiza* (*Radix Salviae* dripping pill, CDDP) can protect endothelial diastolic function, vision, and visual acuity, improve microvascular structure, and improve retinal microcirculation. Therefore, *Radix Salviae* can safely and effectively delay the progression of DR and loss of vision, providing a new treatment for DR (Fig. [8](#Fig8){ref-type="fig"}).Fig. 8Illustration of the crucial biological processes caused by putative targets and known therapeutic targets for DR. *MMP2* matrix metallopeptidase 2, *hsp60* heat shock protein 60, *Cyt3* cytochrome 3, *PLG* plasminogen, *PLM* plasmin, *tPA* tissue plasminogen activator, *PAI* plasminogen activator inhibitor, *RECK* reversion-inducing cysteine-rich protein with Kazal motifs, *MMP9* matrix metallopeptidase 9, *TIMP 1* tissue inhibitor of metalloproteinases 1, *TIMP 2* tissue inhibitor of metalloproteinases 2, *TIMP 4* tissue inhibitor of metalloproteinases 4, *ECM* extracellular matrix, *IGF-1* insulin-like growth factor-1, *IGF-1R* insulin-like growth factor-1 receptor, *PI3K* phosphatidylinositol 3-kinase, *AKT* serine-threonine kinase, *VEGF* vascular endothelial growth factor, *KDR* vascular endothelial growth factor receptor 2, *AQP-1* aquaporin-1, *COX-2* cyclooxygenase-2, *PGH2* prostaglandin H2, *PGE2* prostaglandin E2, *PGES* prostaglandin E2 synthase

However, there are some limitations in the use of network pharmacological methods to predict active ingredients and potential mechanisms. (i) The screened active ingredients may be inconsistent with the actual absorbed components in the blood of patients with DR; (ii) it may be difficult to distinguish the inhibitory effect from the target activation effect; (iii) the predicted results may be affected by possible deviation in highly studied pathways and functions; and (iv) the interaction relationships between the nodes in the network construction methods are still unclear. Therefore, further experimental verification of the potential active ingredients is needed to verify this theoretical prediction.

Conclusions {#Sec28}
===========

This study used a scientific approach to decipher the pharmacological mechanisms of *Radix Salviae* in the treatment of DR. We discovered that the effects may be associated with anti-angiogenesis, the inhibition of apoptosis, and the inflammatory response. Among these crucial biological functions, eight targets were identified as key active factors involved in the related pathways. This research suggests that *Radix Salviae* can alleviate DR via the molecular mechanisms predicted by network pharmacology and that the network pharmacology approach can be an effective tool to reveal the mechanisms of TCM. However, to improve the reliability of the results, further experimental experiments are needed to validate these results.
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